1. Home
  2. AVLN vs HLF Comparison

AVLN vs HLF Comparison

Compare AVLN & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$28.73

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$12.32

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVLN
HLF
Founded
N/A
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2026
2004

Fundamental Metrics

Financial Performance
Metric
AVLN
HLF
Price
$28.73
$12.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$18.00
AVG Volume (30 Days)
258.9K
1.3M
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.57
Revenue
N/A
$5,037,500,000.00
Revenue This Year
N/A
$4.97
Revenue Next Year
N/A
$3.80
P/E Ratio
N/A
$21.89
Revenue Growth
N/A
0.89
52 Week Low
$24.90
$7.56
52 Week High
$33.32
$20.40

Technical Indicators

Market Signals
Indicator
AVLN
HLF
Relative Strength Index (RSI) 43.91 47.77
Support Level $26.68 $11.47
Resistance Level $29.59 $12.82
Average True Range (ATR) 1.99 0.44
MACD 0.19 0.01
Stochastic Oscillator 61.44 39.15

Price Performance

Historical Comparison
AVLN
HLF

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

Share on Social Networks: